News
BIO Boston: 2025 is shaping up to be a year of challenge – but also opportunity – say biotech bosses
So, what were the major themes to come out of BIO Boston 2025? Who’s getting excited about what? And – besides the obvious ...
"Despite this decision of the Court of Justice, the European Commission continues to refuse to make the messages public," ...
Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes ...
Biogen has been trying to build up its R&D pipeline as it faces increased competition for its biggest-selling products like ...
Technology has also improved immunisation operations with the use of online appointment scheduling that automates ...
A series of adverts for weight-loss services have been banned by the Advertising Standards Authority in the UK for promoting ...
Is chaos in US health policy creating new global opportunities? With major leadership and policy shake-ups the US healthcare ...
From robot-assisted surgery to personalised disease treatment - technology can do some truly remarkable things. But while the ...
It is the second licensing deal that AbbVie has negotiated this year for a trispecific for multiple myeloma, coming in the ...
In 2023, Varda sent a pharma manufacturing capsule into space to test a crystallisation process for HIV therapy ritonavir, a ...
Respondents broadly supported clearer guidance on how evidence on health inequalities should be presented and how impacts are ...
Medistry LLC is the internet registry operator of the .med top level domain (TLD). Currently in a period of pre-registration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results